Objective: To analyze the mutant spectrum of clonal hematopoiesis of indeterminate potential (CHIP) related mutations and clinical characteristics and to explore the correlation and the possible mechanism between CHIP-related mutations and cardio-cerebrovasculars events (CCEs) in patients with myeloproliferative neoplasms (MPNs).
Methods: The clinical data and next-generation sequencing results of 73 MPN patients in Beijing Anzhen Hospital from August 2019 to July 2022 were retrospectively analyzed. Statistical analyses were conducted by multivariate logistic regression for the effects of CHIP-related mutations and inflammatory cytokines on CCEs for MPNs patients.
Results: Fifty-five cases of MPN (75.3%) showed positive in CHIP-related genes. There was no significant difference in variant allele frequency of CHIP-related gene between essential thrombocythemia (ET) and polycythemia vera (PV). CHIP-related gene mutations were mainly single gene mutations, with mutation rate from high to low as JAK2V617F (63.0%, 46/73), ASXL1 (16.4%, 12/73), TET2 (11.0%, 8/73), DNMT3A (9.6%, 7/73), SRSF2 (6.9%, 5/73), SF3B1 (4.1%, 3/73), TP53(1.4%, 1/73) and PPM1D (1.4%, 1/73). The mutation rate of CHIP-related genes in MPN patients >60 years old was significantly higher than that in the patients ≤60 years old ［91.7%(33/36) vs 59.5%(22/37)］. CCEs occurred in 27 MPNs patients (37.0%, MPNs/CCEs), and 5 had recurrent CCEs, all of which were arterial events. Age (62.8±12.8 years vs 53.9±15.8 years, P =0.015), IL-1β level (17.7±26.0 vs 4.3±8.6, P =0.012), IL-8 level (360.7±598.6 vs 108.3±317.0, P =0.045), the proportion of the patients with thrombosis history (29.6% vs 2.2%, P =0.020), and the detection rate of CHIP-related mutations (88.9% vs 67.4%, P =0.040) in the group with CCEs were higher than those in the group without CCEs. Multivariate Logistic regression analysis showed that age（OR =0.917， 95%CI ：0.843-0.999, P =0.047）, thrombosis history (OR =34.148， 95%CI ：2.392-487.535, P =0.009), any CHIP-related mutations(OR =16.065， 95%CI ：1.217-212.024， P =0.035), and elevated level of IL-1β (OR =0.929， 95%CI ：0.870-0.992， P =0.027) were independent risk factors for MPNs/CCEs. CHIP-related gene mutations were not associated with CCEs in MPN patients, but DNMT3A (OR =88.717， 95%CI ：2.690-292.482， P =0.012) and ASXL1 (OR =7.941， 95%CI ：1.045-60.353， P =0.045) were independent risk factors for CCEs in PV.
Conclusion: There is a higher mutation rate of CHIP-related genes in MPN patients, especially those over 60 years old. Older age, thrombosis history, CHIP-related mutations and IL-1β elevated levels are independent risk factors for CCEs in MPN. DNMT3A and ASXL1 mutations are independent risk factors for CCEs in PV patients. CHIP-related gene mutations and inflammatory cytokine IL-1 β elevated levels may be the novel risk factors for CCEs in MPN.
题目: CHIP相关基因与MPN患者心脑血管事件的风险分析.
目的: 分析骨髓增殖性肿瘤（MPN）患者不确定潜能的克隆性造血(CHIP)相关基因突变谱和临床特征，探讨CHIP相关基因与其心脑血管事件（CCE）的相关性及可能作用机制。.
方法: 回顾性分析2019年8月-2022年7月首都医科大学附属北京安贞医院血液科收治的73例MPN患者的临床资料和二代测序结果，采用Logistic回归分析CHIP相关基因、炎症细胞因子对MPN患者CCE的影响。.
结果: 55例（75.3%）MPN患者检出CHIP相关基因，原发性血小板增多症（ET）和真性红细胞增多症（PV）患者CHIP相关基因各突变频率差异无统计学意义。CHIP相关基因突变以单基因形式为主，检出率从高至低依次为JAK2V617F（63.0%，46/73）、ASXL1（16.4%，12/73）、TET2（11.0%，8/73）、DNMT3A（9.6%，7/73）、SRSF2（6.9%，5/73）、SF3B1（4.1%，3/73）、TP53（1.4%，1/73）和PPMID（1.4%，1/73）。年龄＞60岁患者CHIP相关基因检出率明显高于≤60岁者［91.7%（33/36） vs 59.5%（22/37）］。27例（37.0%）MPN患者伴CCE（MPN/CCE），2次CCE者5例，均为动脉事件。CCE组患者年龄（62.8±12.8 vs 53.9±15.8岁，P =0.015）、IL-1β水平（17.7±26.0 vs 4.3±8.6，P =0.012）、IL-8水平（360.7±598.6 vs 108.3±317.0，P =0.045）、血栓形成史（29.6% vs 2.2%，P =0.020）和CHIP相关基因检出率（88.9% vs 67.4%，P =0.040）高于无CCE组。多因素Logistic回归分析结果显示，年龄（OR =0.917，95%CI ：0.843-0.999，P =0.047）、血栓形成史（OR =34.148，95%CI ：2.392-487.535，P =0.009）、任何1个CHIP相关基因突变（OR =16.065，95%CI ：1.217-212.024，P =0.035）和IL-1β水平升高（OR =0.929，95%CI ：0.870-0.992，P =0.027）均是MPN/CCE的独立危险因素；CHIP相关单基因突变与MPN/CCE无关，但DNMT3A（OR =88.717，95%CI ：2.690-292.482，P =0.012）、ASXL1（OR =7.941，95%CI ：1.045-60.353，P =0.045）突变是PV/CCE的独立危险因素。.
结论: MPN患者CHIP相关基因突变率高，尤其是60岁以上患者；高龄、血栓形成史、CHIP相关基因突变和IL-1β水平升高是MPN发生CCE的独立危险因素。DNMT3A、ASXL1单基因突变是PV患者CCE的独立危险因素。CHIP相关基因突变及炎症细胞因子IL-1β升高是MPN新的CCE危险因素。.
Keywords: inflammatory cytokine; CHIP-related mutation; cardio-cerebrovasculars events; myeloproliferative neoplasms.